Prof Stellah Mpagama

Honorary Professor

Researcher profile

Selected publications

• Open access

  A pragmatic trial with an optimized dose of rifampicin and moxifloxacin for the treatment of drug-susceptible pulmonary tuberculosis: a study protocol for open-label, randomized phase III trial (OptiRiMoxTB)

  Mlyuka, H. J., Liyoyo, A., Nyaulingo, B., Mpolya, E., Kaswaga, O. L., Semvua, H., Lwambura, S., McHugh, T. D., Wildner, L., Sabiiti, W., Adegbite, B. R., Nliwasa, M., Khosa, C., Mbelele, P., Mbeya, B., Jeremiah, K., Boeree, M. J., Gillespie, S. H., Sloan, D. J. & Mpagama, S. G. & 1 others, SimpliciTB Consortium, 25 Feb 2026, In: Trials. 27, p. 1-14 14 p., 182.

  Research output: Contribution to journal › Article › peer-review

• Open access

  Multimorbidity and the risk of post-tuberculosis lung disease: a systematic review and meta-analysis

  Hill, K. J., Mbabazi, I., Scopazzini, M. S., Warner, B., Sekaggya Wiltshire, C., Mills, S., Mpagama, S., Stagg, H. R. & Sloan, D. J., 1 Jun 2026, In: BMJ Global Health. 11, 6, p. 1-15 15 p., e020365.

  Research output: Contribution to journal › Review article › peer-review

• Open access

  Cardiac safety of bedaquiline, delamanid and moxifloxacin co-administered with or without varying doses of sutezolid or delpazolid for the treatment of drug-susceptible TB

  Koele, S. E., Stoycheva, K., Mtweve, C., Manyama, C., Mpagama, S., Mhimbira, F., Wallis, R., Ntinginya, N. E., Liyoyo, A., Huglin, B., Minja, L. T., Wagnerberger, L., Zumba, T., Noreña, I., Peter, D. D., Beattie, T., Makkan, H., Sloan, D. J., Te Brake, L. & Aarnoutse, R. E. & 9 others, McHugh, T. D., Wildner, L., Schildkraut, J., Aldana, B. H., Phillips, P. P. J., Hoelscher, M., Svensson, E. M., Heinrich, N. & PanACEA Consortium, Aug 2025, In: Journal of Antimicrobial Chemotherapy. 80, 8, p. 2305-2313 9 p.

  Research output: Contribution to journal › Article › peer-review

• Open access

  Multimorbidity in tuberculosis (TB) and its impact on patient care (MITICare): a cross-sectional study nested within a prospective cohort study protocol

  Hill, K., Owori, R., Naisanga, M., Owarwo, N., Mills, S., Stagg, H. R., Mpagama, S., Sekaggya-Wiltshire, C. & Sloan, D., 25 Aug 2025, In: Wellcome Open Research. 10, p. 1-10 10 p., 282.

  Research output: Contribution to journal › Article › peer-review

• Open access

  Safety, bactericidal activity, and pharmacokinetics of the antituberculosis drug candidate BTZ-043 in South Africa (PanACEA-BTZ-043–02): an open-label, dose-expansion, randomised, controlled, phase 1b/2a trial

  Heinrich, N., de Jager, V., Dreisbach, J., Gross-Demel, P., Schultz, S., Gerbach, S., Kloss, F., Dawson, R., Narunsky, K., Matt, L., Wildner, L., McHugh, T. D., Fuhr, U., Aldana, B. H., Mouhdad, C., Brake, L. T., Boeree, M. J., Aarnoutse, R. E., Svensson, E. M. & Gong, X. & 4 others, P J Phillips, P., Diacon, A. H., Hoelscher, M. & PanACEA-TB consortium, Feb 2025, In: The Lancet Microbe. 6, 2, p. 1-12 12 p., 100952.

  Research output: Contribution to journal › Article › peer-review

See more publications